Background: Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common type of a group of transmissible spongiform encephalopathies (prion diseases). The etiology of the sporadic form of CJD is still unclear. sCJD can occur in combination with other neurodegenerative diseases, which further complicates the diagnosis. Alzheimer's disease (AD), e.g., is often seen in conjunction with sCJD. Method: In this study, we performed a systematic analysis of 15 genes related to the most important neurodegenerative diseases - AD, frontotemporal dementia, amyotrophic lateral sclerosis, prion disease, and Parkinson's disease - in a cohort of sCJD and sCJD in comorbidity with AD and primary age-related proteinopathy (PART). A total of 30 neuropathologically verified cases of sCJD with and without additional proteinopathies were included in the study. In addition, we compared microtubule-associated protein tau (MAPT) haplotypes between sCJD patients and patients with sCJD and PART or sCJD and AD. Then we studied the interaction between the Apolipoprotein E gene (APOE) and PRNP in sCJD patients. Results: We did not find any causal mutations in the neurodegenerative disease genes. We did detect a p.E318G missense variant of uncertain significance (VUS) in PSEN1 in three patients. In PRNP, we also found a previously described non-pathogenic insertion (p.P84_Q91Q). Conclusion: Our pilot study failed to find any critical differences between pure sCJD and sCJD in conjunction with other comorbid neurodegenerative diseases. Further investigations are needed to better understand this phenomenon.

Department of Biomedical Sciences University of Antwerp Antwerp Belgium

Department of Neurology 3rd Faculty of Medicine Charles University and Thomayer Hospital Prague Czechia

Department of Pathology 1st Faculty of Medicine Charles University and General University Hospital Prague Czechia

Department of Pathology 3rd Faculty of Medicine Charles University and Kralovske Vinohrady University Hospital Prague Czechia

Department of Pathology and Molecular Medicine 3rd Faculty of Medicine Charles University and Thomayer Hospital Prague Czechia

National Reference Laboratory for Human Prion Diseases Thomayer Hospital Prague Czechia

Neurodegenerative Brain Diseases Group VIB Center for Molecular Neurology Vlaams Instituut voor Biotechnologie Antwerp Belgium

See more in PubMed

Ross CA, Poirier MA. Protein aggregation sand neurodegenerative disease. Nat Med. (2004) 10:S10–7. 10.1038/nm1066 PubMed DOI

Santiago JA, Bottero V, Potashkin JA. Dissecting the molecular mechanisms of neurodegenerative diseases through network biology. Front Aging Neurosci. (2017) 9:166. 10.3389/fnagi.2017.00166 PubMed DOI PMC

Braak H. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. (1991) 82:239–59. 10.1007/BF00308809 PubMed DOI

Arneson D, Zhang Y, Yang X, Narayanan M. Shared mechanisms among neurodegenerative diseases: from genetic factors to gene networks. J Genet. (2018) 97:795–806. 10.1007/s12041-018-0963-3 PubMed DOI PMC

Sikorska B, Knight R, Ironside JW, Liberski PP. Creutzfeldt-Jakob disease. Adv Exp Med Biol. (2012) 724:76–90. 10.1007/978-1-4614-0653-2_6 PubMed DOI

Kovacs GG, Rahimi J, Ströbel T, Lutz MI, Regelsberger G, Streichenberger N, et al. . Tau pathology in Creutzfeldt-Jakob disease revisited. Brain Pathol. (2017) 27:332–44. 10.1111/bpa.12411 PubMed DOI PMC

Reiniger L, Lukic A, Linehan J, Rudge P, Collinge J, Mead S, et al. . Tau, prions and Aβ: the triad of neurodegeneration. Acta Neuropathol. (2011) 121:5–20. 10.1007/s00401-010-0691-0 PubMed DOI PMC

Kovacs GG, Seguin J, Quadrio I, Höftberge R, Kapás I, Streichenberger N, et al. . Genetic Creutzfeldt-Jakob disease associated with the E200K mutation: characterization of a complex proteinopathy. Acta Neuropathol. (2011) 121:39–57. 10.1007/s00401-010-0713-y PubMed DOI

Tousseyn T, Bajsarowicz K, Sanchez H, Gheyara A, Oehler A, Geschwind M, et al. . Prion disease induces alzheimer disease-like neuropathologic changes. J Neuropathol Exp Neurol. (2015) 74:873–88. 10.1097/NEN.0000000000000228 PubMed DOI PMC

Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, et al. . Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. (2014) 128:755–66. 10.1007/s00401-014-1349-0 PubMed DOI PMC

Bell WR, An Y, Kageyama Y, English C, Rudow GL, Pletnikova O, et al. . Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy (PART) and Alzheimer's disease. Alzheimers Dement. (2019) 15:8–16. 10.1016/j.jalz.2018.07.215 PubMed DOI PMC

Rossi M, Kai H, Baiardi S, Bartoletti AS, Carla B, Zenesini C, et al. . The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins. Acta Neuropathol Commun. (2019) 7:53. 10.1186/s40478-019-0706-6 PubMed DOI PMC

Kim D, Kim HS, Choi SM, Kim BC, Lee MC, Lee KH, et al. . Primary age-related tauopathy: an elderly brain pathology frequently encountered during autopsy. J Pathol Transl Med. (2019) 53:159–63. 10.4132/jptm.2019.03.14 PubMed DOI PMC

Josephs KA, Murray ME, Tosakulwong N, Whitwel JL, Knopman DS, Machulda MM, et al. . Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). Acta Neuropathol. (2017) 133:705–15. 10.1007/s00401-017-1681-2 PubMed DOI PMC

Jicha GA, Parisi JE, Dickson DW, Cha RH, Johnson KA, Smith GE, et al. . Age and apoE associations with complex pathologic features in Alzheimer's disease. J Neurol Sci. (2008) 273:34–9. 10.1016/j.jns.2008.06.008 PubMed DOI PMC

Alzheimer's Association 2016 Alzheimer's disease facts and figures. Alzheimer Dement. (2016) 12:459–509. 10.1016/j.jalz.2016.03.001 PubMed DOI

Mackenzie G, Will R. Creutzfeldt-Jakob disease: recent developments. F1000Res. (2017) 6:2053. 10.12688/f1000research.12681.1 PubMed DOI PMC

Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, et al. . Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. (2012) 132:2659–68. 10.1093/brain/awp191 PubMed DOI PMC

Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. . National Institute on aging-Alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. (2012) 8:1–13. 10.1016/j.jalz.2011.10.007 PubMed DOI PMC

Goossens D, Moens LN, Nelis E, Lenaerts AS, Glassee W, Kalbe W, et al. . Simultaneous mutation and copy number variation (CNV) detection by multiplex PCR-based GS-FLX sequencing. Hum Mutat. (2009) 30:472–6. 10.1002/humu.20873 PubMed DOI

Bagyinszky E, Giau VV, Youn YC, An SSA, Kim S. Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases. Neuropsychiatr Dis Treat. (2018) 14:2067–85. 10.2147/NDT.S165445 PubMed DOI PMC

Morales R, Callegari K, Soto C. Prion-like features of misfolded Aβ and tau aggregates. Virus Res. (2015) 207:106–12. 10.1016/j.virusres.2014.12.031 PubMed DOI

Jucker M, Walker LC. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature. (2013) 501:45–51. 10.1038/nature12481 PubMed DOI PMC

Eisele YS, Duyckaerts C. Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol. (2016) 131:5–25. 10.1007/s00401-015-1516-y PubMed DOI

Calero O, Bullido MJ, Clarimón J, Frank-García A, Martínez-Martín P, Lleó A, et al. . Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases. PLoS ONE. (2011) 6:e22090. 10.1371/journal.pone.0022090 PubMed DOI PMC

Salvatore M, Seeber AC, Nacmias B, Petraroli P, D'Alessandro M, Sorbi S, et al. . Apolipoprotein E in sporadic and familial creutzfeldt-Jakob disease. Neurosci Lett. (1995) 199:95–98. 10.1016/0304-3940(95)12030-8 PubMed DOI

Amouyel P, Vidal O, Launay JM, Laplanche JL. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French research group on epidemiology of human spongiform encephalopathies. Lancet. (1994) 344:1315–18. 10.1016/S0140-6736(94)90691-2 PubMed DOI

Wei Y, Tang Y, He W, Qu Z, Zeng J, Qin Ch. APOE gene polymorphisms and susceptibility to Creutzfeldt-Jakob disease. J Clin Neurosci. (2004) 21:390t4. 10.1016/j.jocn.2013.07.019 PubMed DOI

Verpillat P, Camuzat A, Hannequin D, Thomas AC, Puel M, Belliard S, et al. . Association between the extended tau haplotype and frontotemporal dementia. Arch Neurol. (2002) 59:935–9. 10.1001/archneur.59.6.935 PubMed DOI

Sánchez-Valle R, Pastor P, Yagüe J, Ribalta T, Graus F, Tolosa E, et al. . Analysis of the exon 1 polymorphism in the Tau gene in transmissible spongiform encephalopathies. J Neurol. (2002) 249:938–9. 10.1007/s00415-002-0717-1 PubMed DOI

Myers AJ, Kaleem M, Marlowe L, Pittman AM, Lees AJ, Fung HC, et al. . The H1c haplotype at the MAPT locus is associated with Alzheimer's disease. Hum Mol Genet. (2005) 14:2399–2404. 10.1093/hmg/ddi241 PubMed DOI

Allen M, Kachadoorian M, Quicksall Z, Zou F, Seng Chai H, Younkin C, et al. . Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels. Alzheimers Res Ther. (2014) 6:39. 10.1186/alzrt268 PubMed DOI PMC

Aulić S, Masperone L, Narkiewicz J, Isopi E, Bistaffa E, Ambrosetti E, et al. . α-synuclein amyloids hijack prion protein to gain cell entry, facilitate cell-to-cell spreading and block prion replication. Sci Rep. (2017) 7:10050. 10.1038/s41598-017-10236-x PubMed DOI PMC

Crosiers D, Theuns J, Cras P, Van Broeckhoven C. Parkinson disease: insights in clinical, genetic and pathological features of monogenic disease subtypes. J Chem Neuroanat. (2011) 42:131–41. 10.1016/j.jchemneu.2011.07.003 PubMed DOI

Giau VV, Senanarong V, Bagyinszky E, An SSA, Kim S. Analysis of 50 neurodegenerative genes in clinically diagnosed early-onset Alzheimer's disease. Int J Mol Sci. (2019) 20:1514. 10.3390/ijms20061514 PubMed DOI PMC

Biomarkers Analysis and Clinical Manifestations in Comorbid Creutzfeldt-Jakob Disease: A Retrospective Study in 215 Autopsy Cases

Human Prion Disorders: Review of the Current Literature and a Twenty-Year Experience of the National Surveillance Center in the Czech Republic